Logo image of IMXI

INTERNATIONAL MONEY EXPRESS (IMXI) Stock Fundamental Analysis

NASDAQ:IMXI - Nasdaq - US46005L1017 - Common Stock - Currency: USD

18.1  -0.31 (-1.68%)

Premarket: 18.41 +0.31 (+1.71%)

Fundamental Rating

6

IMXI gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Financial Services industry. Both the health and profitability get an excellent rating, making IMXI a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on IMXI. These ratings would make IMXI suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IMXI was profitable.
IMXI had a positive operating cash flow in the past year.
IMXI had positive earnings in each of the past 5 years.
IMXI had a positive operating cash flow in 4 of the past 5 years.
IMXI Yearly Net Income VS EBIT VS OCF VS FCFIMXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.67%, IMXI belongs to the top of the industry, outperforming 94.06% of the companies in the same industry.
The Return On Equity of IMXI (42.96%) is better than 94.06% of its industry peers.
With an excellent Return On Invested Capital value of 24.26%, IMXI belongs to the best of the industry, outperforming 96.04% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IMXI is significantly above the industry average of 7.75%.
The 3 year average ROIC (20.19%) for IMXI is below the current ROIC(24.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.67%
ROE 42.96%
ROIC 24.26%
ROA(3y)11.75%
ROA(5y)11.38%
ROE(3y)36.96%
ROE(5y)36.35%
ROIC(3y)20.19%
ROIC(5y)20.12%
IMXI Yearly ROA, ROE, ROICIMXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

1.3 Margins

IMXI has a Profit Margin (9.15%) which is comparable to the rest of the industry.
IMXI's Profit Margin has declined in the last couple of years.
IMXI's Operating Margin of 15.17% is in line compared to the rest of the industry. IMXI outperforms 52.48% of its industry peers.
In the last couple of years the Operating Margin of IMXI has grown nicely.
Industry RankSector Rank
OM 15.17%
PM (TTM) 9.15%
GM N/A
OM growth 3Y-0.63%
OM growth 5Y11.21%
PM growth 3Y-1.53%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMXI Yearly Profit, Operating, Gross MarginsIMXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

7

2. Health

2.1 Basic Checks

IMXI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for IMXI has been reduced compared to 1 year ago.
Compared to 5 years ago, IMXI has less shares outstanding
Compared to 1 year ago, IMXI has a worse debt to assets ratio.
IMXI Yearly Shares OutstandingIMXI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
IMXI Yearly Total Debt VS Total AssetsIMXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 4.14 indicates that IMXI is not in any danger for bankruptcy at the moment.
The Altman-Z score of IMXI (4.14) is better than 87.13% of its industry peers.
The Debt to FCF ratio of IMXI is 1.58, which is an excellent value as it means it would take IMXI, only 1.58 years of fcf income to pay off all of its debts.
IMXI's Debt to FCF ratio of 1.58 is fine compared to the rest of the industry. IMXI outperforms 76.24% of its industry peers.
A Debt/Equity ratio of 0.97 indicates that IMXI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.97, IMXI is in line with its industry, outperforming 43.56% of the companies in the same industry.
Although IMXI does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.58
Altman-Z 4.14
ROIC/WACC1.83
WACC13.26%
IMXI Yearly LT Debt VS Equity VS FCFIMXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

IMXI has a Current Ratio of 1.80. This is a normal value and indicates that IMXI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.80, IMXI is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
A Quick Ratio of 1.80 indicates that IMXI should not have too much problems paying its short term obligations.
The Quick ratio of IMXI (1.80) is better than 71.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.8
IMXI Yearly Current Assets VS Current LiabilitesIMXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

5

3. Growth

3.1 Past

IMXI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.22%, which is quite good.
IMXI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.88% yearly.
IMXI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.78%.
Measured over the past years, IMXI shows a quite strong growth in Revenue. The Revenue has been growing by 19.19% on average per year.
EPS 1Y (TTM)16.22%
EPS 3Y29.88%
EPS 5YN/A
EPS Q2Q%19.61%
Revenue 1Y (TTM)3.78%
Revenue growth 3Y22.63%
Revenue growth 5Y19.19%
Sales Q2Q%-0.28%

3.2 Future

The Earnings Per Share is expected to grow by 14.05% on average over the next years. This is quite good.
Based on estimates for the next years, IMXI will show a small growth in Revenue. The Revenue will grow by 2.27% on average per year.
EPS Next Y13.88%
EPS Next 2Y12.44%
EPS Next 3Y14.05%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y1.4%
Revenue Next 3Y2.27%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IMXI Yearly Revenue VS EstimatesIMXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
IMXI Yearly EPS VS EstimatesIMXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.42, which indicates a very decent valuation of IMXI.
IMXI's Price/Earnings ratio is a bit cheaper when compared to the industry. IMXI is cheaper than 77.23% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 30.30, IMXI is valued rather cheaply.
The Price/Forward Earnings ratio is 7.34, which indicates a rather cheap valuation of IMXI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMXI indicates a rather cheap valuation: IMXI is cheaper than 84.16% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.06. IMXI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.42
Fwd PE 7.34
IMXI Price Earnings VS Forward Price EarningsIMXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMXI is valued cheaper than 95.05% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMXI is valued cheaper than 93.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.44
EV/EBITDA 4.76
IMXI Per share dataIMXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

IMXI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMXI may justify a higher PE ratio.
IMXI's earnings are expected to grow with 14.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y12.44%
EPS Next 3Y14.05%

0

5. Dividend

5.1 Amount

IMXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTERNATIONAL MONEY EXPRESS

NASDAQ:IMXI (2/20/2025, 8:00:01 PM)

Premarket: 18.41 +0.31 (+1.71%)

18.1

-0.31 (-1.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)02-26 2025-02-26/amc
Inst Owners88.72%
Inst Owner Change-3.4%
Ins Owners4.42%
Ins Owner Change-0.78%
Market Cap562.91M
Analysts73.33
Price Target26.32 (45.41%)
Short Float %3.04%
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.02%
Min EPS beat(2)-4.92%
Max EPS beat(2)2.89%
EPS beat(4)3
Avg EPS beat(4)2.02%
Min EPS beat(4)-4.92%
Max EPS beat(4)5.18%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)4.65%
EPS beat(16)12
Avg EPS beat(16)4.6%
Revenue beat(2)0
Avg Revenue beat(2)-3.23%
Min Revenue beat(2)-3.81%
Max Revenue beat(2)-2.65%
Revenue beat(4)0
Avg Revenue beat(4)-3.43%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)-2.65%
Revenue beat(8)0
Avg Revenue beat(8)-2.5%
Revenue beat(12)1
Avg Revenue beat(12)-1.93%
Revenue beat(16)5
Avg Revenue beat(16)-0.65%
PT rev (1m)-1.4%
PT rev (3m)6.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.05%
EPS NY rev (1m)0%
EPS NY rev (3m)0.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 8.42
Fwd PE 7.34
P/S 0.85
P/FCF 6.44
P/OCF 4.73
P/B 3.97
P/tB 7.93
EV/EBITDA 4.76
EPS(TTM)2.15
EY11.88%
EPS(NY)2.47
Fwd EY13.62%
FCF(TTM)2.81
FCFY15.52%
OCF(TTM)3.83
OCFY21.15%
SpS21.4
BVpS4.56
TBVpS2.28
PEG (NY)0.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.67%
ROE 42.96%
ROCE 33.65%
ROIC 24.26%
ROICexc 50.76%
ROICexgc 100.34%
OM 15.17%
PM (TTM) 9.15%
GM N/A
FCFM 13.12%
ROA(3y)11.75%
ROA(5y)11.38%
ROE(3y)36.96%
ROE(5y)36.35%
ROIC(3y)20.19%
ROIC(5y)20.12%
ROICexc(3y)49.86%
ROICexc(5y)46.62%
ROICexgc(3y)115.58%
ROICexgc(5y)N/A
ROCE(3y)28%
ROCE(5y)27.9%
ROICexcg growth 3Y23.66%
ROICexcg growth 5Y3.29%
ROICexc growth 3Y16.85%
ROICexc growth 5Y24.88%
OM growth 3Y-0.63%
OM growth 5Y11.21%
PM growth 3Y-1.53%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.58
Debt/EBITDA 1.21
Cap/Depr 237.71%
Cap/Sales 4.76%
Interest Coverage 9.73
Cash Conversion 104.17%
Profit Quality 143.35%
Current Ratio 1.8
Quick Ratio 1.8
Altman-Z 4.14
F-Score8
WACC13.26%
ROIC/WACC1.83
Cap/Depr(3y)114.65%
Cap/Depr(5y)86.88%
Cap/Sales(3y)2.19%
Cap/Sales(5y)1.96%
Profit Quality(3y)122.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.22%
EPS 3Y29.88%
EPS 5YN/A
EPS Q2Q%19.61%
EPS Next Y13.88%
EPS Next 2Y12.44%
EPS Next 3Y14.05%
EPS Next 5YN/A
Revenue 1Y (TTM)3.78%
Revenue growth 3Y22.63%
Revenue growth 5Y19.19%
Sales Q2Q%-0.28%
Revenue Next Year0%
Revenue Next 2Y1.4%
Revenue Next 3Y2.27%
Revenue Next 5YN/A
EBIT growth 1Y8.91%
EBIT growth 3Y21.86%
EBIT growth 5Y32.55%
EBIT Next Year30.63%
EBIT Next 3Y13.22%
EBIT Next 5YN/A
FCF growth 1Y1332.02%
FCF growth 3YN/A
FCF growth 5Y55.47%
OCF growth 1Y1478.95%
OCF growth 3YN/A
OCF growth 5Y48.55%